Skip to main content

Widening Sino‐EU policy and research cooperation in Personalised Medicine


Report: Mapping the scientific and Policy Landscape of PerMed in China, including the identification of stakeholders

A systematic mapping of available literature (scientific papers and patents) will be carried out to describe, in a comprehensive, transparent and objective manner the R&I landscape of PerMed in China, the main areas in which research is being performed, and innovation activities and cooperation with European researchers.The results of this mapping will be an important input to activities in WP 3 and 4.

Report: Preliminary analysis of Strengths, Weaknesses, Barriers and Gaps for ICPerMed‐China Cooperation. Document for discussion in the workshop

Results of the previous tasks will be used to prepare a first analysis of the context of PerMed in China, in terms of Research effort, policy commitment and relevance within the main stakeholder groups. This first analysis will provide a first insight on: countries where Personalised Medicine is already an issue of interest; countries which already have research groups working in this field, how far PM is being contemplated or up taken in public health policies, who are the main actors to be addressed for the sake of the project's objective, etc.

Searching for OpenAIRE data...